drugset / Trial / NCT01244659
A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment
RandomizedParallel-groupOpen-labelTreatment
Summary
Comparison of safety and efficacy of immunosuppressive regiments using tacrolimus from EMS and Prograf® in post renal transplanted patients.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-08
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | 0.2 mg/kg | — |
| Background | Methylprednisolone | Other / unclassified | 30 mg | — |
| Background | mycophenolic acid | Small molecule | 720 mg | — |
| Background | mycophenolic acid | Small molecule | 1440 mg | — |
Indications
No indication recorded.